Plasma pre beta1-HDL level is elevated in unstable angina pectoris

Area of Science:

• Cardiovascular Medicine
• Lipid Metabolism
• Biochemistry

Background:

• Pre beta1-HDL, a minor high-density lipoprotein (HDL) subfraction, is crucial for reverse cholesterol transport.
• Elevated plasma pre beta1-HDL levels are linked to coronary artery disease (CAD) and dyslipidemia.
• Understanding the clinical significance of pre beta1-HDL is essential for cardiovascular risk assessment.

Purpose of the Study:

• To investigate the clinical significance of plasma pre beta1-HDL levels in patients with CAD.
• To compare pre beta1-HDL levels between CAD patients (stable and unstable) and controls.
• To determine if pre beta1-HDL levels correlate with the atherosclerotic phase of CAD.

Main Methods:

• Quantification of plasma pre beta1-HDL levels using a specific monoclonal antibody immunoassay (Mab55201).
• Study included 112 CAD patients (76 stable CAD, 36 unstable angina pectoris) and 30 controls.
• Analysis performed on both general patient groups and after excluding dyslipidemic subjects.

Main Results:

• CAD patients exhibited significantly higher mean pre beta1-HDL levels compared to controls (34.8 vs. 26.6 mg/L, p<0.001).
• Unstable angina pectoris subgroup showed markedly higher pre beta1-HDL levels than the stable CAD subgroup (43.1 vs. 30.9 mg/L, p<0.0001).
• These associations persisted even after excluding individuals with dyslipidemia.

Conclusions:

• Elevated plasma pre beta1-HDL levels are associated with the atherosclerotic progression in CAD.
• Pre beta1-HDL may serve as a valuable biomarker for identifying patients with unstable angina pectoris.
• Further research can explore pre beta1-HDL's role in risk stratification and therapeutic strategies for CAD.